Trial Profile

A Phase IV, single dose, open labelled, comparative, randomized controlled study to evaluate the immunogenicity and safety of BBIL's JENVAC (Inactivated JE Vaccine) vs. Chinese SA-14-14-2 (Live JE Vaccine) vaccine in healthy volunteers.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 31 Dec 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Japanese encephalitis vaccine (Primary) ; Japanese encephalitis vaccine (Primary)
Indications Japanese encephalitis
Focus Pharmacodynamics
Sponsors Bharat Biotech

20 Dec 2019 Results assessing persistence of immune response with an inactivated Japanese encephalitis single dose vaccine JENVAC and interchangeability with a live-attenuated vaccine published in the Journal of Infectious Diseases
05 Dec 2018 Status changed from recruiting to completed.
19 Mar 2014 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com